Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma

被引：12

作者：

Kalac, Matko ^{[1
,2
,11
]}

Jain, Salvia ^{[3
]}

Tam, Constantine S. ^{[4
,5
]}

Xiao, Zhengrui ^{[6
]}

Montanari, Francesca ^{[7
]}

Kanakry, Jennifer ^{[8
]}

Huber, Bryan D. ^{[9
]}

Goldfinger, Mendel ^{[6
]}

O'Connor, Owen A.

Marchi, Enrica ^{[10
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Hematol & Oncol, New York, NY USA

[2] Univ Calif Irvine, Dept Hematol & Oncol, Irvine, CA USA

[3] Massachusetts Gen Hosp, Dept Med, Boston, MA USA

[4] Monash Univ, Melbourne, Vic, Australia

[5] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia

[6] Albert Einstein Coll Med, Dept Med, New York, NY USA

[7] Yale Univ Canc Ctr, Dept Hematol, Greenwich, CT USA

[8] NCI, Expt Transplantat & Immunotherapy Branch, NIH, Bethesda, MD USA

[9] Intermt Med Grp, Blood & Marrow Transplant Acute Leukemia Program, Salt Lake City, UT USA

[10] Univ Virginia Canc Ctr, Div Hematol & Oncol, Charlottesville, VA USA

[11] Univ Calif Irvine, Tisch Canc Inst, 200 S Manchester Ave, Orange, CA 92868 USA

来源：

BLOOD ADVANCES | 2023年 / 7卷 / 14期

关键词：

MUTATIONS; TET2;

D O I：

10.1182/bloodadvances.2022009445

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3760 / 3763

页数：4

共 50 条

[41] Extracorporeal photopheresis as a treatment for patients with cutaneous T-cell lymphoma: real-world data at a reference cancer centre in Colombia
Toquica, A.
Enciso-Olivera, L.
Rueda-Lozada, X.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (10) : E780 - E781
[42] Azacitidine for Injection Combined with Chidamide in Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase I Study
Yu, Jingwei
Lu, Yaxiao
Yao, Yixin
Liu, Xianming
Li, Lanfang
Qian, Zhengzi
Qiu, Lihua
Zhou, Shiyong
Wang, Xianhuo
Zhang, Huilai
BLOOD, 2023, 142
[43] Failure of Romidepsin to Treat Relapsed/Refractory Peripheral T-Cell Lymphoma in Children: A Single-center Experience
Tandon, Sneha
Bartram, Jack
Kyriakopoulou, Lianna
Kanwar, Nisha
Lo, Winnie
Davidson, Scott
Punnett, Angela
Shlien, Adam
Hitzler, Johann
Malkin, David
Villani, Anita
Abla, Oussama
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (05) : E745 - E748
[44] Outcomes of 48 patients with primary angioimmunoblastic T-cell lymphoma in real-world clinical practice: a single-center experience
Huang, Chen
Zhang, Huichao
Zhao, Guimin
Ma, Guangyu
Wu, Xiaolin
Gao, Yuhuan
Diao, Lanping
Liu, Lihong
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 861 - 872
[45] Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience
Murai, Kazunori
Hiroyuki, Hamada
Sato, Akiyoshi
Yasuro, Miyairi
Mori, Yasuki
Sakuma, Tsutomu
BLOOD, 2017, 130
[46] TREATMENT STRATEGIES, OUTCOMES OF PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA
Roy, A.
Parikh, R.
Pandey, Y.
Yarlagadda, N.
Sasapu, A.
JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 571 - 572
[47] Nursing Roles in Cardiac Safety: Romidepsin in Patients With T-Cell Lymphoma
Hronek, Jan
Reed, Maureen Lehner
ONCOLOGY NURSING FORUM, 2016, 43 (02) : 227 - 234
[48] A Multicenter, Phase III Study of Chidamide, Azacitidine Combined with CHOP Versus CHOP in Patients with Untreated Peripheral T-Cell Lymphoma
Wei, Chong
Zhang, Yan
Li, Jian
Zhang, Wei
Zhou, Daobin
BLOOD, 2022, 140 : 6567 - 6568
[49] Peripheral T cell lymphoma: clinical utility of romidepsin
Zain, Jasmine
Sawey, Kathryn
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2012, 2 : 109 - 115
[50] Prognosis and treatment of patients with peripheral T-cell lymphoma: The MD Anderson Cancer Center experience
Pozadzides, J. V.
Perini, G.
Hess, M.
Romaguera, J. E.
Hagemeister, F. B.
McLaughlin, P.
Fayad, L.
Khouri, I. F.
Hosing, C.
Pro, B.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

← 1 2 3 4 5 →